These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. Lim YH, Kim IH, Seo JJ. J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809 [Abstract] [Full Text] [Related]
3. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey. Ergin C, Ergin S, Kaleli I, Kaçar N, Sengül M, Erdoğan BS. J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100 [No Abstract] [Full Text] [Related]
4. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB. J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337 [Abstract] [Full Text] [Related]
5. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Schafer F, Fich F, Lam M, Gárate C, Wozniak A, Garcia P. Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195 [Abstract] [Full Text] [Related]
6. Resistance of propionibacteria to antibiotics used in the treatment of acne. Brown JM, Poston SM. J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016 [Abstract] [Full Text] [Related]
7. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones. Resh W, Stoughton RB. Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675 [Abstract] [Full Text] [Related]
8. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. Luk NM, Hui M, Lee HC, Fu LH, Liu ZH, Lam LY, Eastel M, Chan YK, Tang LS, Cheng TS, Siu FY, Ng SC, Lai YK, Ho KM. J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749 [Abstract] [Full Text] [Related]
9. [In vitro sensitivity of Corynebacterium acnes (Propionibacterium acnes) to meclocycline, clindamycin, erythromycin and neomycin]. Lucca L, Vittadini G. G Ital Chemioter; 1979 Jan; 26(1-2):203-6. PubMed ID: 554810 [No Abstract] [Full Text] [Related]
10. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study. Abdel Fattah NS, Darwish YW. J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041 [Abstract] [Full Text] [Related]
11. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains. Gloor M, Wasik B, Becker A, Höffler U. Dermatology; 2002 Dec; 205(3):260-4. PubMed ID: 12399674 [Abstract] [Full Text] [Related]
12. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Jain A, Sangal L, Basal E, Kaushal GP, Agarwal SK. Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757 [Abstract] [Full Text] [Related]
13. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5. Akamatsu H, Nishijima S, Takahashi M, Ushijima T, Asada Y. J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712 [Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris. Kurokawa I, Nishijima S, Kawabata S. Eur J Dermatol; 1999 May; 9(1):25-8. PubMed ID: 9920982 [Abstract] [Full Text] [Related]
15. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H. Eur J Dermatol; 2005 May; 15(3):152-5. PubMed ID: 15908296 [Abstract] [Full Text] [Related]
16. Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates. Olsson J, Davidsson S, Unemo M, Mölling P, Andersson SO, Andrén O, Söderquist B, Sellin M, Elgh F. APMIS; 2012 Oct; 120(10):778-85. PubMed ID: 22958285 [Abstract] [Full Text] [Related]
17. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S. Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569 [Abstract] [Full Text] [Related]
18. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris. Feuillolay C, Pecastaings S, Le Gac C, Fiorini-Puybaret C, Luc J, Joulia P, Roques C. Phytomedicine; 2016 Mar 15; 23(3):307-15. PubMed ID: 26969384 [Abstract] [Full Text] [Related]
19. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes. Gans EH, Kligman AM. J Dermatolog Treat; 2002 Sep 15; 13(3):107-10. PubMed ID: 12227872 [Abstract] [Full Text] [Related]
20. Bacterial resistance in French acne patients. Dumont-Wallon G, Moyse D, Blouin E, Dréno B. Int J Dermatol; 2010 Mar 15; 49(3):283-8. PubMed ID: 20465665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]